{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:55:31Z","timestamp":1784264131965,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ijpharm.2012.06.061","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T15:32:30Z","timestamp":1341588750000},"page":"478-485","source":"Crossref","is-referenced-by-count":22,"title":["In vivo evaluation of the highly soluble oral \u03b2-cyclodextrin\u2013Sertraline supramolecular complexes"],"prefix":"10.1016","volume":"436","author":[{"given":"Joel J.","family":"Passos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico B.","family":"De Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iram M.","family":"Mundim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo R.","family":"Bonfim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice F.","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline D.","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milene","family":"Borsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stela M.K.","family":"Rates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n D.","family":"Sinisterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.06.061_bib0005","unstructured":"Allen, D.J.M., Sysko, R.J., 1993. Sertraline Polymorph, US Patent number 5,248,699."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2008.06.004","article-title":"Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes","volume":"130","author":"Auguste","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0020","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1107\/S0108270199008343","article-title":"The absolute configuration of sertraline (Zoloft) hydrochloride","volume":"55","author":"Caruso","year":"1999","journal-title":"Acta Crystallogr. C: Cryst. Struct. Commun."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0025","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.biomaterials.2008.12.013","article-title":"PLGA\u2013lecithin\u2013PEG core\u2013shell nanoparticles for controlled drug delivery","volume":"30","author":"Chan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: advances in modelling human depression and anxiety","volume":"4","author":"Cryan","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nrd1576","article-title":"Cyclodextrin-based pharmaceutics: past, present and future","volume":"3","author":"Davis","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0040","doi-asserted-by":"crossref","first-page":"9910","DOI":"10.1039\/c0jm01903h","article-title":"Photo-response behavior of electrospun nanofibers based on spiropyran\u2013cyclodextrin modified polymer","volume":"20","author":"De Sousa","year":"2010","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0045","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1039\/c2cp22768a","article-title":"Superstructure based on \u03b2-CD self-assembly induced by small guest molecule","volume":"14","author":"De Sousa","year":"2012","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0050","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0032-9592(03)00258-9","article-title":"Cyclodextrins and their uses: a review","volume":"39","author":"Del Valle","year":"2004","journal-title":"Process Biochem."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0055","first-page":"79","article-title":"Physicochemical characterization and in vitro dissolution behavior of nicardipine\u2013cyclodextrins inclusion compounds","volume":"15","author":"Fernandes","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0040-6031(01)00665-7","article-title":"Thermal analysis of cyclodextrins and their inclusion compounds","volume":"380","author":"Giordano","year":"2001","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nchem.893","article-title":"Macroscopic self-assembly through molecular recognition","volume":"3","author":"Harada","year":"2011","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-409X(98)00058-1","article-title":"Cyclodextrin-based controlled drug release system","volume":"36","author":"Hirayama","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0080","series-title":"Sertraline Hydrochloride Analytical Profiles of Drug Substances and Excipients","author":"Johnson","year":"1996"},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0939-6411(02)00127-3","article-title":"Influence of \u03b2-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets","volume":"55","author":"Koester","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0939-6411(01)00144-8","article-title":"Complexation of phenytoin with some hydrophilic cyclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice","volume":"52","author":"Latrofa","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0095","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1590\/S0103-50532011000900020","article-title":"Study of the BPP7a peptide and its \u03b2-cyclodextrin complex: physicochemical characterization and complete sequence specific NMR assignments","volume":"22","author":"Lula","year":"2011","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0100","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jpba.2007.04.005","article-title":"Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants","volume":"44","author":"Malfara","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.110.167346","article-title":"An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats","volume":"57","author":"Marques","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0110","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/mrc.1093","article-title":"Solid-Sate CP\/MAS 13C NMR studies on conformational polymorphism in sertraline hydrochloride, an antidepressant drug","volume":"40","author":"Novoselsky","year":"2002","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejpb.2006.11.023","article-title":"Loading and delivery of sertraline using inorganic micro and mesoporous materials","volume":"66","author":"Nunes","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijpharm.2011.09.026","article-title":"Multi-equilibrium system based on sertraline and \u03b2-cyclodextrin supramolecular complex in aqueous solution","volume":"421","author":"Passos","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijpharm.2008.09.046","article-title":"Complexation with beta-cyclodextrin confers oral activity on the flavonoid dioclein","volume":"367","author":"Rezende","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.saa.2006.03.013","article-title":"Ab initio and density functional computations of the vibrational spectrum, molecular geometry and some molecular properties of the antidepressant drug sertraline (Zoloft) hydrochloride","volume":"66","author":"Sagdinc","year":"2007","journal-title":"Spectrochim. Acta A: Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0135","series-title":"Thermal Analysis of Materials","author":"Speyer","year":"1994"},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test \u2013 a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0145","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1007\/s11095-006-0252-3","article-title":"Dog colonoscopy model for predicting human colon absorption","volume":"23","author":"Sutton","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0150","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/cr970022c","article-title":"Introduction and general overview of cyclodextrin chemistry","volume":"98","author":"Szejtli","year":"1998","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/157340606777723997","article-title":"Physico-chemical profiling of antidepressive sertraline: solubility, ionization, lipophilicity","volume":"2","author":"Tak\u00e1cs-Nov\u00e1k","year":"2006","journal-title":"Med. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejpb.2009.04.018","article-title":"Improvement of oral bioavailability of flurbiprofen from flurbiprofen\/\u03b2-cyclodextrin inclusion complex by action of cinnarizine","volume":"73","author":"Tokumura","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.06.061_bib0165","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.saa.2007.01.010","article-title":"Structure investigation of sertraline drug and its iodine product using mass spectrometry, thermal analyses and MO-calculations","volume":"68","author":"Zayed","year":"2007","journal-title":"Spectrochim. Acta A: Mol. Biomol. Spectrosc."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312006606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312006606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T09:25:45Z","timestamp":1542878745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312006606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0378517312006606"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.06.061","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}